Pneumovax 23 Injection

Regulated Product — Business License Required

B2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.

Product photography not yet supplied — this space will show official packaging imagery once provided by the business.

Product Overview

Pneumovax 23 Injection is a 23-valent pneumococcal polysaccharide vaccine. Its labelling describes it as providing protection against 23 types of Streptococcus pneumoniae bacteria, which can cause pneumonia, meningitis, and ear and blood infections. It is described for adults aged 65 and over, for people aged 2 and over with certain chronic conditions or a weakened immune system, and it is administered by a healthcare professional.

Active ingredient
Pneumococcal purified capsular polysaccharides (23 serotypes)
Dosage form
Solution for intramuscular or subcutaneous injection
Therapeutic class
Bacterial polysaccharide vaccine (active immunisation)
Regulatory status
Prescription / regulated — confirmed per enquiry and destination market
Availability
Confirmed per enquiry

Product Information

The following description reflects information associated with the 23-valent pneumococcal polysaccharide vaccine and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.

Described Uses

  • Described for the prevention of invasive pneumococcal disease in adults and in children aged 2 years and older
  • Described for adults aged 65 years and over
  • Described for people with chronic heart, lung, kidney, or liver conditions, or diabetes
  • Described for people with a weakened immune system, including cancer and HIV-positive patients
Note: SDO Pharma has not independently verified the manufacturer’s efficacy claims for this product and makes no additional medical or clinical claims beyond what is described here. We do not claim FDA, UAE, EU, or other specific regulatory approval for this product unless independently verified. This is a prescription / regulated-status product; patient dispensing is the responsibility of the licensed business customer, not SDO Pharma.

Described Dosage & Administration

  • Administered only by a doctor or nurse into the muscle — not self-administered
  • Described as most people needing only one dose
  • A booster dose is described as recommended about five years after the first dose in some people, per manufacturer guidance

Described Side Effects

Commonly described side effects include:

  • Injection-site reactions (pain, redness)
  • Fever
  • Tiredness (fatigue)

These are described as temporary. If they worsen, or for any severe, persistent, or unexpected reaction, prompt medical attention is required.

Precautions

  • The doctor should be told about any heart, liver, or kidney problems
  • The doctor should be told about all other medicines being taken, as the vaccine is described as possibly interacting with them
  • Pregnant women and breastfeeding mothers should consult their doctor before receiving the vaccine
  • Any previous allergic reaction to a vaccine or vaccine component should be disclosed beforehand

This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.

B2B, Import & Export

B2B, Import & Export Enquiries

SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.

We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.

Product Enquiry

Request Product Information

Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.

Frequently Asked Questions

Per its labelling it is a 23-valent pneumococcal polysaccharide vaccine used to help prevent pneumococcal disease in adults and in children aged 2 years and older at increased risk, including older adults and people with certain chronic conditions or a weakened immune system. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.

Its labelling states it is administered by a doctor or nurse into the muscle. Most people are described as needing only one dose, with a booster after about five years recommended in some people. It is not self-administered.

Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.

Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.

Explore More

Related Product Categories

SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.

View Products & Services